Health News: [cancer]: Drug maker Novartis loses India patent battle

Yahoo! Health   |  My alerts   |   Edit Alert Monday, Apr 01, 2013 06:03 AM EDT

Health News : cancer - News from Yahoo !   Drug maker Novartis loses India patent b... Mon, 01 Apr, 2013 03:01 AM PDT India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated versi... Continue reading Novartis shares hit one-year low after p... Mon, 01 Apr, 2013 02:58 AM PDT Shares in Novartis' Indian unit plunged to a 14-month low on Monday, while rivals climbed after the ... Continue reading Novartis headquarters in Basel, Switzerl... Mon, 01 Apr, 2013 02:58 AM PDT Swiss pharmaceuticals giant Novartis headquarters building is pictured on January 28, 2009 in Basel.... Continue reading Activists demonstrate against multinatio... Mon, 01 Apr, 2013 01:57 AM PDT Activists demonstrate against multinational pharmaceutical company Novartis in New Delhi, July 10, 2... Continue reading India court rejects pharma patent in lan... Mon, 01 Apr, 2013 01:57 AM PDT Activists demonstrate against multinational pharmaceutical company Novartis in New Delhi, July 10, 2... Continue reading The headquarters of the drug giant Novar... Mon, 01 Apr, 2013 01:57 AM PDT The Novartis headquarters in Basel, Switzerland, October 25, 2011. The Supreme Court ruled that the ... Continue reading File picture of a logo on a building of ... Mon, 01 Apr, 2013 01:35 AM PDT File picture of a logo on a building of Swiss drug maker Novartis before its annual general meeting ... Continue reading

Health News : cancer - Top images.

Health News : cancer - News from other sources.   Novartis: Will continue with our investments in India, although catiously Mon, 01 Apr, 2013 03:00 AM PDT The Supreme Court today rejected Swiss drugmaker Novartis AG's plea for a patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over foreign ... Continue reading Leominster MP Bill Wiggin supports prostate cancer care campaign Mon, 01 Apr, 2013 02:55 AM PDT LEOMINSTER MP Bill Wiggin has voiced his support for a Prostate Cancer UK initiative designed to help all men affected by the illness receive the best possible care and information. Continue reading The Conspiracy To End Cancer Mon, 01 Apr, 2013 02:54 AM PDT The hero scientist who defeats cancer will likely never exist. No exalted individual, no victory celebration, no Marie Curie or Jonas Salk, who in 1955, after he created the first polio vaccine, was asked, So what's next? Cancer? — as if a doctor finished with one disease could simply shift his ... Continue reading Novartis judgement: What it means for you Mon, 01 Apr, 2013 02:46 AM PDT The Supreme Court on Monday rejected Swiss drugmaker Novartis AG's plea for patent protection of its cancer drug Glivec. The Supreme Court's decision comes after a legal battle that began when Novarti... Continue reading Drug maker Novartis loses India patent battle - NBC40.net Mon, 01 Apr, 2013 02:45 AM PDT NEW DELHI (AP) - India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. Continue reading Scott & White seeks volunteers for research study Mon, 01 Apr, 2013 02:43 AM PDT Scott & White Healthcare is looking for volunteers to join a research study about physical activity in cancer survivors. Continue reading SC decision on Novartis to benefit poor patients: Pharma cos Mon, 01 Apr, 2013 02:42 AM PDT Poor patients will have easier access to quality medicines with the Supreme Court rejecting Swiss firm Novartis' patent plea for its cancer drug Glivec, according to domestic manufacturers. Continue reading Drug maker Novartis loses India patent battle - Quincy Herald-Whig | Illinois & Missouri News, Sports Mon, 01 Apr, 2013 02:41 AM PDT NEW DELHI (AP) - India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. Continue reading

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.